Genomic Prediction
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Genomic Prediction sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Genomic Prediction: 6 sponsored US clinical trials, 4 recruiting.
Genomic Prediction sponsors 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting. The most-studied condition in this pipeline is Infertility, with 3 trials.
Upper-quartile sponsor footprint
Genomic Prediction sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
NCT06141135
Preimplantation Genetic Testing in Women of Advanced Maternal Age
NCT04167748
Embryo Health Study
NCT04528498
Follow-up With Preimplantation Genetic Testing Patients
NCT04477863
ANXA5 M2 Haplotyping in IVF Patients and Embryos
NCT04544462
Cell Free Preimplantation Genetic Testing
NCT04628507
Therapeutic Areas
What is open in the Genomic Prediction pipeline
4 recruiting of 6 indexed (67% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Infertility (3 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Genomic Prediction: open-pipeline peers nationwide
Peers matched on 6 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
Genomic Prediction sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
- Alexander B Olawaiye, MD · 67% recruiting · 3 trials
Related
What to do with this Genomic Prediction page
6 registered trials is a research-attention snapshot, not an endorsement of Genomic Prediction or any single study.
- 4 of Genomic Prediction's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Infertility is the condition Genomic Prediction studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infertility trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Genomic Prediction pipeline card: 6 registered trials from official public datasets.Report a data error.